HOCHDORF Holding AG

EQS-Adhoc: HOCHDORF Holding AG: Forward Integration in Baby Care


EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Letter of Intent
HOCHDORF Holding AG: Forward Integration in Baby Care

25.07.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.


--------------------------------------------------------------------------------
HOCHDORF Group Press Release: Forward Integration in Baby Care

Forward integration with Pharmalys Laboratories SA under examination

Hochdorf, 25 July 2016-HOCHDORF Holding Ltd previously announced the integration
of downstream stages of the value creation stream as one of its strategic aims,
particularly for the international market. In the area of Baby Care there is now
mutual interest with Pharmalys Laboratories SA in pursuing an integration with
the HOCHDORF Group. AMemorandum of Understanding has been signed to this effect.

HOCHDORF Holding Ltd does not currently supply the end consumer market in the
Baby Care area through its subsidiary HOCHDORF Swiss Nutrition Ltd. This would
change with a majority shareholding in Pharmalys Laboratories SA, based in Baar
(ZG).

Active in 42 countries
The Pharmalys Group has a staff of more than 500 direct and indirect employees
around the world. The company markets infant nutrition under the Primalac brand;
it also markets infant nutrition and cereals under the Swisslac brand. Its
products are available in 42 countries in Europe, Asia, Africa and the Middle
East. Pharmalys Laboratories SA is a company that has shown rapid growth: a
HOCHDORF customer since 2008, Pharmalys expects to achieve sales of CHF 70
million this year with a two-figure increase in the EBIT Margins. The company is
seeking to double its turnover and EBIT in the next two years.

"We have achieved a very rapid growth in recent years with HOCHDORF products and
we would like to continue in this vein. An integration can guarantee our access
to the high-quality HOCHDORF products. In return HOCHDORF will receive direct
access to consumers in our highly attractive markets," explained founder and CEO
of the Pharmalys Group, Amir Mechria.

As part of this transaction, HOCHDORF will secure a call option for majority
share in the Dubai-based Phamena Ltd, which is also part of the Pharmalys Group.
Phamena Ltd operates exclusively in the Libyan market.

Dr Thomas Eisenring, CEO of the HOCHDORF Group is delighted with the Memorandum
of Understanding: "The HOCHDORF Group is striving towards forward integration in
the area of infant nutrition. An association with one of our largest customers
is exactly in keeping with our strategy. We have enjoyed excellent collaboration
with Pharmalys for years," he said.

The next step will be to negotiate a purchase agreement. Adoption of the
purchase agreement will depend on a variety of conditions. It may not be derived
from either the Memorandum of Understanding or this press release that HOCHDORF
Holding Ltd has acquired a minority or majority shareholding in Pharmalys
Laboratories SA either now or in the future.

End of ad hoc announcement
Additional features:


Document:http://n.eqs.com/c/fncls.ssp?u=EFBURFFCIK
Document title: HOCHDORF Group Press Release Forward Integration

--------------------------------------------------------------------------------
25.07.2016 News transmitted by Tensid EQS AG. www.eqs.com

--------------------------------------------------------------------------------
Information and Explanation of the Issuer to this News:


In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a
consolidated gross sales revenue of CHF 551.2 million. It is one of the leading
foodstuff companies in Switzerland, with more than 625 employees as at 31
December 2015. Made from such natural ingredients as milk, wheat germ, and
oilseeds, HOCHDORF products have been contributing to the health and well-being
of the young and old alike since 1895. Our customers include the food industry
and wholesalers and retailers. Our products are sold in more than 90 countries.
HOCHDORF stock is traded on the SIX Swiss Exchange in Zurich (ISIN
CH0024666528).


--------------------------------------------------------------------------------

Language: English

Company:  HOCHDORF Holding AG

          Siedereistrasse 9

          6281 Hochdorf

          Switzerland

Phone:    +41 41 914 65 65

Fax:      +41 41 914 66 66

E-mail:hochdorf@hochdorf.com

Internet: www.hochdorf.com

ISIN:     CH0024666528

Listed:   Foreign Exchange(s) SIX


End of News EQS Group News Service
--------------------------------------------------------------------------------
485325  25.07.2016 
 

 


Weitere Meldungen: HOCHDORF Holding AG

Das könnte Sie auch interessieren: